Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q2 2011 · —
Revenue$1.98B$1.98B+2.4% vs Q2 2010 Net Income$146.00M$146.00M+49.0% vs Q2 2010 EPS Diluted$0.10$0.10+66.7% vs Q2 2010 Gross Profit$1,287,000,000+1.0% Operating Income$237,000,000+2.6% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
$390,000,000
+36.4%
Free Cash Flowderived$307,000,000+36.4% Margins · derivedGross margin65.2%−0.9 pt vs Q2 2010
Operating margin12.0%+0.0 pt vs Q2 2010
Net margin7.4%+2.3 pt vs Q2 2010